Disruptive Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers (NCT06797427) | Disruptive Pharma | 2025-02-10 |
Track Disruptive Pharma automatically
Every clearance here is in the API, with alerts when new ones post.